FDA approves nivolumab with chemotherapy as neoadjuvant treatment for certain patients with resectable NSCLC marzo 7, 2022
Sequencing of cancer cell genomes reveals potential new drug targets for an aggressive type of lung cancer marzo 18, 2014
